Effective Study: Development and Application of a Question-Driven, Time-Effective Cardiac Magnetic Resonance Scanning Protocol.
cardiomyopathy
cardiovascular magnetic resonance
ischemic heart disease
rapid scanning
time‐effectiveness
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
04 01 2022
04 01 2022
Historique:
pubmed:
1
1
2022
medline:
9
4
2022
entrez:
31
12
2021
Statut:
ppublish
Résumé
Background Long scanning times impede cardiac magnetic resonance (CMR) clinical uptake. A "one-size-fits-all" shortened, focused protocol (eg, only function and late-gadolinium enhancement) reduces scanning time and costs, but provides less information. We developed 2 question-driven CMR and stress-CMR protocols, including tailored advanced tissue characterization, and tested their effectiveness in reducing scanning time while retaining the diagnostic performances of standard protocols. Methods and Results Eighty three consecutive patients with cardiomyopathy or ischemic heart disease underwent the tailored CMR. Each scan consisted of standard cines, late-gadolinium enhancement imaging, native T1-mapping, and extracellular volume. Fat/edema modules, right ventricle cine, and in-line quantitative perfusion mapping were performed as clinically required. Workflow was optimized to avoid gaps. Time target was <30 minutes for a CMR and <35 minutes for a stress-CMR. CMR was considered impactful when its results drove changes in diagnosis or management. Advanced tissue characterization was considered impactful when it changed the confidence level in the diagnosis. The quality of the images was assessed. A control group of 137 patients was identified among scans performed before February 2020. Compared with standard protocols, the average scan duration dropped by >30% (CMR: from 42±8 to 28±6 minutes; stress-CMR: from 50±10 to 34±6 minutes, both
Identifiants
pubmed: 34970923
doi: 10.1161/JAHA.121.022605
pmc: PMC9075206
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e022605Références
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):728-731
pubmed: 33325495
J Cardiovasc Magn Reson. 2017 Apr 7;19(1):43
pubmed: 28385161
Magn Reson Med. 2009 Jan;61(1):215-21
pubmed: 19097213
Circulation. 2016 Aug 2;134(5):432-4
pubmed: 27482005
JACC Cardiovasc Imaging. 2020 Jul;13(7):1632-1634
pubmed: 32305472
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17
pubmed: 32089132
J Cardiovasc Magn Reson. 2013 Jan 18;15:9
pubmed: 23331632
Circulation. 2019 Apr 30;139(18):e891-e908
pubmed: 30913893
J Cardiovasc Magn Reson. 2020 Nov 9;22(1):76
pubmed: 33161900
Int J Cardiovasc Imaging. 2019 Oct;35(10):1893-1901
pubmed: 31104178
J Am Heart Assoc. 2018 Sep 4;7(17):e008981
pubmed: 30371164
JACC Cardiovasc Imaging. 2016 Nov;9(11):1338-1348
pubmed: 27832901
J Am Heart Assoc. 2018 Sep 4;7(17):e010435
pubmed: 30371155
N Engl J Med. 2019 Jun 20;380(25):2418-2428
pubmed: 31216398
Eur Heart J. 2013 Mar;34(10):775-81
pubmed: 22390914